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Introduction
The reference method to determine glomerular filtration
rate (GFR) in children is the inulin clearance. Similarly,
Cr51-EDTA, iohexol and iothalamate can be used as ex-
ogenous GFR markers [1,2]. Exogenous markers are ex-
pensive and rather impractical. Creatinine is by far the
most commonly used biochemical marker of renal func-
tion. The commonest principle for assaying creatinine is
the Jaffe reaction [3]. Since Jaffe only observed a complex-
ation between picric acid and creatinine in alkaline environ-
ment and never described an analytical method, variation
amongst ‘Jaffe method’ recipes is broad [4]. The analytical
bias of current creatinine methods (due to interference by
pseudochromogens and calibration differences) is still dis-
appointing: the compensated Jaffe method shows a small
positive bias, whereas a major positive bias is observed for
the dry chemistry and the uncompensated Jaffe methods
[5]. Interlaboratory variation for creatinine is still unac-
ceptably high; recent studies have reported median method
group variation coefficients of 6.4% at a concentration of
80 µmol/L [6]. Such variation leads to an unacceptable vari-
ation in the estimation of kidney function in young children
and infants. Equations to estimate GFR require knowledge
of the calibration of the serum creatinine assay [7].
Restandardization of creatinine
Recently, a new commutable serum creatinine reference
material (NIST SRM 967) has become available. This ma-
terial is value assigned with the gas chromatography iso-
tope dilution mass spectrometry (GC-IDMS) and liquid
chromatography isotope dilution mass spectrometry (LC-
IDMS) reference measurement procedures. Implementing
traceability of serum creatinine assays to the new standard
material will lead to major changes in the clinical decision-
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making criteria currently used for serum creatinine and
creatinine clearance [7].
In the earliest manual and automated methods, serum
creatinine was assayed by the Jaffe reaction after depro-
teinization or dialysis, eliminating the pseudo-chromogen
effect of proteins. Modern analysers use undiluted serum
and plasma, making them prone to the so-called protein er-
ror in the alkaline picrate reaction [8]. In the serum of adults,
this effect produces a positive difference of ∼27 µmol/L
(±0.3 mg/dL) creatinine compared with HPLC or enzy-
matic methods [8]. Because urine contains relatively little
or no protein, the protein error affects only creatinine
determinations in serum or plasma. Therefore, creatinine
clearance is underestimated when creatinine methods af-
fected by protein error are used. For calculating GFR, this
systematic positive bias is greatly compensated by the over-
estimation attributable to tubular secretion of creatinine,
which is relatively more important in children [8].
Serum or plasma creatinine values are often used for es-
timating GFR [8]. For adults, the currently recommended
estimating equation has been developed from the Modifi-
cation of Diet in Renal Disease (MDRD) Study [9]. The
current variability in the calibration of serum creatinine
assays introduces a source of error into GFR estimates. In
particular, variability in creatinine calibration and measure-
ment imprecision contributes to substantial uncertainty in
estimating GFR in children, who usually have lower serum
creatinine concentrations than adults. The recent availabil-
ity of the international NIST SRM 967 standard means an
important milestone in the improvement of GFR estimation
in adults [10].
Consequences of creatinine restandardization
For adults, an improved GFR-estimating equation based on
serum creatinine values traceable to IDMS reference mea-
surement procedures has been presented [7]. Manufacturers
can restandardize their Jaffe creatinine assays using a so-
called compensation, a mathematical correction that com-
pensates for analytical non-specificity due to the protein
error. Since children show lower reference ranges for total
protein, this protein error is considerably smaller [11]. In
consequence, use of restandardized Jaffe-type assays results
in overcompensation when used in children or infants (oc-
casionally even leading to negative values in children with
a decreased muscle mass!). Enzymatic methods manage to
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Table 1. Example of creatinine-based GFR estimation problems in a 4-










Non-compensated Jaffe 0.71 77.5 60.6
Compensated Jaffe (adapted to SRM
967)
0.41 134.1 105
Enzymatic (adapted to SRM 967) 0.47 117 91
measure the serum creatinine more correctly. Due to the
elimination of analytical non-specificity, the lower enzy-
matic creatinine result (when the result has not been ad-
justed to Jaffe-like results) leads to markedly increased cre-
atinine clearance and GFR values because of the increased
effect of tubular secretion. Paradoxically, the analytical im-
provement makes creatinine less suited as a GFR marker
in paediatric medicine [11]. When creatinine clearance is
measured in patients who have been administered cimeti-
dine, the effect of tubular secretion can be corrected [12].
However, this method cannot be used on a wide scale.
The bias in serum creatinine concentration in the lower
range is a major concern in paediatrics due to the much
lower reference ranges for serum or plasma creatinine in
infants and children [13,14]. For estimating GFR in chil-
dren and infants, the Schwartz [15–17] and the Counahan–
Barratt equations [18] are recommended. Both provide GFR
estimates based on a constant multiplied by the child’s
height divided by the serum creatinine concentration. The
values for the constant used in both equations differ con-
siderably: k = 38 (Counahan) versus k = 48.7 (Schwartz)
[19]. Since these formulas have been validated 30 years ago
(using Jaffe recipes that are no longer on the market), re-
assessment of classical formulas for estimating creatinine
clearance and GFR using modern assays is strongly recom-
mended. Despite the major change in values caused by the
recent standardization, so far no clinically validated adap-
tations of creatinine-based formulas for estimating GFR
in children have been published. It is clear that this will
be difficult; compensated Jaffe results will be less suited
than enzymatic methods as a base for these calculations.
Theoretically, the expression kL/(creatinine) (in which k is
a constant and L the child’s length) could be replaced by
kL/[(creatinine; IDMS calibrated) + non-specificity cor-
rection] when using the new IDMS-calibrated assays. How-
ever, this non-specificity correction shows a variation [8]
that increases the uncertainty of the estimation. It is clear
that extreme care will have to be taken since coefficients
will depend on the method chosen. Table 1 illustrates the
GFR estimation problems in children due to creatinine stan-
dardization.
Alternative markers
Serum concentrations of low-molecular-weight marker pro-
teins are primarily determined by GFR. Cystatin C (Cys
C) is a 13 kDa cysteine protease that is produced by all
nucleated cells [13,20]. The gene is of the house-keeping
type, which is compatible with a stable production rate
even in the presence of inflammatory stimuli. As a GFR
marker in paediatric populations [21], serum Cys C lev-
els generally show diagnostic superiority or equivalence
of serum Cys C versus serum creatinine. Especially in the
blind range of creatinine, Cys C proves to be a superior
marker. Unlike creatinine, serum Cys C reflects renal func-
tion in children independent of age, gender, height and
body composition [21]. Clinicians should be cognizant of a
number of caveats (upregulation in certain tumours, gluco-
corticoid treatment, thyroid dysfunction) that can influence
Cys C results [22,23]. Serum creatinine values are lower in
malnourished children and lead to overestimation of GFR,
while Cys C levels are unaffected [24].
In comparison with the Schwartz formula, Cys C-based
GFR estimates show significantly less bias and serve as
a better estimate for GFR in children [25]. International
standardization for Cys C by an International Federation
of Clinical Chemistry (IFCC) working group is nearing
completion. Beta trace protein (BTP) is a 23–29 kDa pro-
tein, which has been introduced for the measurement of
kidney function in the creatinine-blind range [7,26]. Beta
2-microglobulin has been advocated as a GFR marker [7],
but its serum concentration can increase as an acute-phase
reactant or as a tumour marker in lymphoproliferative dis-
orders [7].
Next steps
Between-laboratory variation of Jaffe-based methods has
not decreased over the last decade, despite technical
progress [5]. Analytical bias in creatinine assays needs to be
reduced and non-specificity bias should be improved and, if
necessary, adapted to a paediatric serum matrix. The creati-
nine standardization issue has major clinical consequences
that are far beyond the significance of the parameter itself.
Apart from the conventional calculation of the creatinine
clearance, also the calculation of the clearance using de-
rived formulas is a key element in the assessment of renal
function and the dose calculation of many drugs [27]. Many
existing drug dosage schemes have been based using poorly
described non-specific ‘Jaffe’ methods.
When introducing revised serum creatinine calibration
traceable to IDMS, laboratories will need to communicate
with paediatricians and pharmacists: serum creatinine ref-
erence intervals will drop, calculations of estimated GFR
used by pharmacists or other health care professionals to
adjust drug dosages will be affected by the decreased crea-
tinine values, measured and calculated creatinine clearance
values and GFR values will increase, and their correspond-
ing reference intervals will be different.
In view of the difficulties in adapting creatinine assays
to the new calibrators in the paediatric concentration range
in a uniform way, the low-molecular-mass proteins Cys C
and BTP offer promising alternatives for calculating GFR,
in particular in children with a decreased muscle mass or
in the blind range of creatinine. In comparison with serum
creatinine, low-molecular-mass proteins have a better di-
agnostic sensitivity for detection of impaired GFR [13,21].
Although some caveats have to be taken into account when
interpreting test results [22,23], the protein-based GFR
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calculations only require serum values. The ongoing
progress in the standardization of these protein assays will
enable the wide-scale use of these methods.
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